Cells and tissues often depend on vascular networks to supply essential nutrients—but in many clinical and industrial contexts, this natural support system is absent. NuNa Bioscience is developing NutriX, a patented and cell-triggered nutrient release platform that helps preserve metabolism outside the body.

To develop immunomodulatory ingredients with evidence-based health benefits for (medical) foods, dietary supplements and animal feeds.

Nydus R&D develops the first human-relevant brainstem organoid platform to transform drug testing for deadly pediatric brain cancers like DMG, bridging the gap between lab research and clinical success.

OcellO offers in vitro assays which recapitulate and quantify complex human biology in a robust and high-throughput format.
We test compounds for oncology, immuno-oncology, inflammation and cystopathy indications.

CellEKT presents a revolutionary approach to kinase inhibitor screening, addressing a critical gap in the drug discovery process.

Omnicin Therapeutics develops Bismocin, an inhaled therapy that restores antibiotic effectiveness against resistant Pseudomonas aeruginosa lung infections in chronic respiratory patients.

OncoChem is pioneering a breakthrough theranostic approach against metastatic pancreatic cancer, one of the deadliest and most treatment-resistant oncological diseases.

Maximizing the potential of organoids could unlock new industrial and clinical applications. Orgonex is determined to tackle major challenges preventing successful translation.

PacingCure develops gene therapies for common cardiac arrhythmias and cardiomyopathies

Panorama Laboratories is building a new class of lab devices. Instead of measuring characteristics of samples, we measure characteristics of protocols while they are being executed. These devices will allow for instant and objective documentation of high impact actions in the lab.